Sfoglia per Autore
Antiangiogenic agents are ineffective to increase complete response rate in MRCC:A meta-analysis
2012 Iacovelli, Roberto; Altavilla, Amelia; Passaro, Antonio; Maria, Campennì Giuseppe; Alesini, Daniele; Palleschi, Michela; Modica, Daniela; Giovannoni, Sara; Manai, Chiara; Cortesi, Enrico
Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies
2012 G., Procopio; E., Verzoni; Iacovelli, Roberto; D., Biasoni; I., Testa; L., Porcu; F., De Braud
Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: A retrospective Italian survey
2012 C., Masini; R., Sabbatini; C., Porta; G., Procopio; G., Di Lorenzo; A., Onofri; S., Buti; Iacovelli, Roberto; R., Invernizzi; L., Moscetti; M. G., Aste; M., Pagano; F., Grosso; Lucia A., Manenti; C., Ortega; L., Cosmai; C., Del Giovane; P. F., Conte
Tumour burden is an independent prognostic factor in metastatic renal cell carcinoma.
2012 Iacovelli, Roberto; Lanoy, E; Albiges, L; Escudier, B.
Medical strategies for treatment of castration resistant prostate cancer (CRPC) docetaxel resistant.
2012 Altavilla, Amelia; Iacovelli, Roberto; Giuseppe, Procopio; Alesini, Daniele; Risi, Emanuela; Giuseppe Maria, Campenni; Palazzo, Antonella; Cortesi, Enrico
Clinical and pathological features of primary renal synovial sarcoma: analysis of 64 cases from 11 years of medical literature.
2012 Iacovelli, Roberto; Altavilla, Amelia; Ciardi, Antonio; Urbano, Federica; Manai, Chiara; Gentile, Vincenzo; Cortesi, Enrico
Gemcitabine-induced extensive skin necrosis
2012 D'Epiro, Sara; Salvi, Monica; Mattozzi, Carlo; Giancristoforo, Simona; Campoli, Marco; Zanniello, Ramona; Luci, Cecilia; Macaluso, Laura; Giovannoni, Sara; Iacovelli, Roberto; Calvieri, Stefano; Richetta, Antonio Giovanni
Abiraterone acetate in castration-resistant prostate cancer
2012 Iacovelli, Roberto; Palazzo, Antonella; Giuseppe, Procopio; Gazzaniga, Paola; Cortesi, Enrico
Post-docetaxel therapy in castration resistant prostate cancer - the forest is growing in the desert.
2012 Altavilla, Amelia; Iacovelli, Roberto; G., Procopio; Cortesi, Enrico
Is there a role for targeted therapies in the collecting ducts of Bellini carcinoma? Efficacy data from a retrospective analysis of 7 cases
2012 G., Procopio; E., Verzoni; Iacovelli, Roberto; M., Colecchia; T., Torelli; L., Mariani
Incidence and risk of pulmonary toxicity in patients treated with mTOR ihibitors for malignancy. A meta-analysis of published trials
2012 Iacovelli, Roberto; Palazzo, Antonella; Mezi, Silvia; Morano, F; Naso, Giuseppe; Cortesi, Enrico
Genital and inguinal cutaneous toxicity in male and female patients treated with sunitinib
2012 Iacovelli, Roberto; Maria Laura, Mancini; Risi, Emanuela; Palazzo, Antonella; Cortesi, Enrico
Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma
2013 M., Santoni; U., De Giorgi; Iacovelli, Roberto; A., Conti; L., Burattini; L., Rossi; Luca S., Burgio; R., Berardi; G., Muzzonigro; Cortesi, Enrico; D., Amadori; S., Cascinu
Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside.
2013 Santoni, M; Santini, D; Massari, F; Conti, A; Iacovelli, Roberto; Burattini, L; Tortora, G; Falconi, M; Montironi, R; Cascinu, S.
Reply to"mTOR inhibitor-related pulmonary toxicity;incidence even higher"
2013 Palazzo, Antonella; Iacovelli, Roberto; Cortesi, Enrico
Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies
2013 S., Antoun; E., Lanoy; Iacovelli, Roberto; L., Albiges Sauvin; Y., Loriot; M., Merad Taoufik; K., Fizazi; M., Di Palma; V. E., Baracos; B., Escudier
Dynamic contrast-enhanced magnetic resonance imaging in the early evaluation of anti-angiogenic therapy in metastatic renal cell carcinoma.
2013 Panebianco, Valeria; Iacovelli, Roberto; Barchetti, Flavio; Altavilla, Amelia; Forte, Valerio; Sciarra, Alessandro; Cortesi, Enrico; Catalano, Carlo
Are post-docetaxel treatments effective in patients with castration-resistant prostate cancer and performance of 2? A meta-analysis of published trials
2013 Iacovelli, Roberto; A., Altavilla; G., Procopio; S., Bracarda; M., Santoni; S., Cascinu; Cortesi, Enrico
Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: Results from a large patient cohort
2013 Iacovelli, Roberto; Giacomo, Carteni; Cora N., Sternberg; Michele, Milella; Matteo, Santoni; Giuseppe Di, Lorenzo; Cinzia, Ortega; Roberto, Sabbatini; Riccardo, Ricotta; Caterina, Messina; Vito, Lorusso; Francesco, Atzori; Fabio De, Vincenzo; Cosimo, Sacco; Francesco, Boccardo; Francesco, Valduga; Francesco, Massari; Valentina, Baldazzi; Saverio, Cinieri; Alessandra, Mosca; Enzo Maria, Ruggeri; Alfredo, Berruti; Linda, Cerbone; Giuseppe, Procopio
Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma
2013 Matteo, Santoni; Silvia, Scoccianti; Ivan, Lolli; Silvano G., Fabrini Mg; Beatrice, Detti; Franco, Perrone; Giuseppina, Savio; Iacovelli, Roberto; Luciano, Burattini; Rossana, Berardi; Stefano, Cascinu
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Antiangiogenic agents are ineffective to increase complete response rate in MRCC:A meta-analysis | 2012 | Iacovelli, Roberto; Altavilla, Amelia; Passaro, Antonio; Maria, Campennì Giuseppe; Alesini, Daniele; Palleschi, Michela; Modica, Daniela; Giovannoni, Sara; Manai, Chiara; Cortesi, Enrico | |
| Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies | 2012 | G., Procopio; E., Verzoni; Iacovelli, Roberto; D., Biasoni; I., Testa; L., Porcu; F., De Braud | |
| Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: A retrospective Italian survey | 2012 | C., Masini; R., Sabbatini; C., Porta; G., Procopio; G., Di Lorenzo; A., Onofri; S., Buti; Iacovelli, Roberto; R., Invernizzi; L., Moscetti; M. G., Aste; M., Pagano; F., Grosso; Lucia A., Manenti; C., Ortega; L., Cosmai; C., Del Giovane; P. F., Conte | |
| Tumour burden is an independent prognostic factor in metastatic renal cell carcinoma. | 2012 | Iacovelli, Roberto; Lanoy, E; Albiges, L; Escudier, B. | |
| Medical strategies for treatment of castration resistant prostate cancer (CRPC) docetaxel resistant. | 2012 | Altavilla, Amelia; Iacovelli, Roberto; Giuseppe, Procopio; Alesini, Daniele; Risi, Emanuela; Giuseppe Maria, Campenni; Palazzo, Antonella; Cortesi, Enrico | |
| Clinical and pathological features of primary renal synovial sarcoma: analysis of 64 cases from 11 years of medical literature. | 2012 | Iacovelli, Roberto; Altavilla, Amelia; Ciardi, Antonio; Urbano, Federica; Manai, Chiara; Gentile, Vincenzo; Cortesi, Enrico | |
| Gemcitabine-induced extensive skin necrosis | 2012 | D'Epiro, Sara; Salvi, Monica; Mattozzi, Carlo; Giancristoforo, Simona; Campoli, Marco; Zanniello, Ramona; Luci, Cecilia; Macaluso, Laura; Giovannoni, Sara; Iacovelli, Roberto; Calvieri, Stefano; Richetta, Antonio Giovanni | |
| Abiraterone acetate in castration-resistant prostate cancer | 2012 | Iacovelli, Roberto; Palazzo, Antonella; Giuseppe, Procopio; Gazzaniga, Paola; Cortesi, Enrico | |
| Post-docetaxel therapy in castration resistant prostate cancer - the forest is growing in the desert. | 2012 | Altavilla, Amelia; Iacovelli, Roberto; G., Procopio; Cortesi, Enrico | |
| Is there a role for targeted therapies in the collecting ducts of Bellini carcinoma? Efficacy data from a retrospective analysis of 7 cases | 2012 | G., Procopio; E., Verzoni; Iacovelli, Roberto; M., Colecchia; T., Torelli; L., Mariani | |
| Incidence and risk of pulmonary toxicity in patients treated with mTOR ihibitors for malignancy. A meta-analysis of published trials | 2012 | Iacovelli, Roberto; Palazzo, Antonella; Mezi, Silvia; Morano, F; Naso, Giuseppe; Cortesi, Enrico | |
| Genital and inguinal cutaneous toxicity in male and female patients treated with sunitinib | 2012 | Iacovelli, Roberto; Maria Laura, Mancini; Risi, Emanuela; Palazzo, Antonella; Cortesi, Enrico | |
| Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma | 2013 | M., Santoni; U., De Giorgi; Iacovelli, Roberto; A., Conti; L., Burattini; L., Rossi; Luca S., Burgio; R., Berardi; G., Muzzonigro; Cortesi, Enrico; D., Amadori; S., Cascinu | |
| Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside. | 2013 | Santoni, M; Santini, D; Massari, F; Conti, A; Iacovelli, Roberto; Burattini, L; Tortora, G; Falconi, M; Montironi, R; Cascinu, S. | |
| Reply to"mTOR inhibitor-related pulmonary toxicity;incidence even higher" | 2013 | Palazzo, Antonella; Iacovelli, Roberto; Cortesi, Enrico | |
| Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies | 2013 | S., Antoun; E., Lanoy; Iacovelli, Roberto; L., Albiges Sauvin; Y., Loriot; M., Merad Taoufik; K., Fizazi; M., Di Palma; V. E., Baracos; B., Escudier | |
| Dynamic contrast-enhanced magnetic resonance imaging in the early evaluation of anti-angiogenic therapy in metastatic renal cell carcinoma. | 2013 | Panebianco, Valeria; Iacovelli, Roberto; Barchetti, Flavio; Altavilla, Amelia; Forte, Valerio; Sciarra, Alessandro; Cortesi, Enrico; Catalano, Carlo | |
| Are post-docetaxel treatments effective in patients with castration-resistant prostate cancer and performance of 2? A meta-analysis of published trials | 2013 | Iacovelli, Roberto; A., Altavilla; G., Procopio; S., Bracarda; M., Santoni; S., Cascinu; Cortesi, Enrico | |
| Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: Results from a large patient cohort | 2013 | Iacovelli, Roberto; Giacomo, Carteni; Cora N., Sternberg; Michele, Milella; Matteo, Santoni; Giuseppe Di, Lorenzo; Cinzia, Ortega; Roberto, Sabbatini; Riccardo, Ricotta; Caterina, Messina; Vito, Lorusso; Francesco, Atzori; Fabio De, Vincenzo; Cosimo, Sacco; Francesco, Boccardo; Francesco, Valduga; Francesco, Massari; Valentina, Baldazzi; Saverio, Cinieri; Alessandra, Mosca; Enzo Maria, Ruggeri; Alfredo, Berruti; Linda, Cerbone; Giuseppe, Procopio | |
| Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma | 2013 | Matteo, Santoni; Silvia, Scoccianti; Ivan, Lolli; Silvano G., Fabrini Mg; Beatrice, Detti; Franco, Perrone; Giuseppina, Savio; Iacovelli, Roberto; Luciano, Burattini; Rossana, Berardi; Stefano, Cascinu |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile